Prosecution Insights
Last updated: October 08, 2026

Morrison & Foerster LLP

Technology area: Biotechnology & Pharmaceuticals

349 pending office actions • 177 clients • 317 examiners • 156 art units • 0 of 349 (0%) have an AI response strategy ready

Analysis

MORRISON & FOERSTER LLP has a history with 24000 career applications in the Biotechnology and Pharmaceuticals technology area. The firm maintains a resolved allowance rate of 78.44 percent. Successful applications require an average of 3.43 office actions per allowance.

The firm currently manages 287 pending office actions. The 24000 career applications reflect the total volume in the biotechnology sector. The 78.44 percent allowance rate and 3.43 average office actions provide a statistical baseline for the firm's performance in life sciences prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=24000 apps, methodology: how we score firms)

78.4%
Allowance Rate
n=24000
+0.56σ
Allowance Rate (norm)
n=24000
3.4
OAs to Allowance
n=12786
-0.06σ
OAs to Allow (norm)
n=12786
1112 days
Time to Allowance
n=12786
+13.9pp
Interview Lift
n=24000
27.7%
RCE Rate
n=24000
1.3%
Appeal Rate
n=24000

Rejection Performance (% of received rejections ultimately overcome)

74.8%
§101 Overcome
n=1548
77.1%
§102 Overcome
n=4725
77.7%
§103 Overcome
n=7737
79.6%
§112 Overcome
n=6193

Specialization & Scale

A61K, A61P, C07K
Top CPC Subclasses
22%
Top-3 CPC Share
n=24000
81
Practitioners
n=24000
296.3
Apps / Practitioner
n=24000

Portfolio Summary

349
Total Pending OAs
239
Non-Final OAs
107
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 113 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

59
Overdue
8
Due this week
29
Due this month
14
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 113 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (59)Due ≤ 7 days (8)Due ≤ 30 days (29)Due ≤ 60 days (14)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

162
Hard (46%)
147
Medium (42%)
34
Easy (10%)
6
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 only8 (2%)
§101 + other54 (15%)
§103 only100 (29%)
§102 only10 (3%)
§112 only30 (9%)
Double-patenting only4 (1%)
Double-patenting + other37 (11%)
Multi-statute (no §101)100 (29%)
No statute on record6 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

154
Life Sciences
44% of docket
27
Information Tech
8% of docket
14
Communications
4% of docket
8
Semiconductors
2% of docket
77
Mechanical / Eng
22% of docket
69
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

3,490 h
Manual time on pending OAs
698 h
Time saved (low, 20%)
1,222 h
Time saved (mid, 35%)
30.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAGE, BRENT T 3 82.4% +10.8%
RAHMAN, MASUDUR 3 72.7% +31.7%
LULTSCHIK, WILLIAM G 2 22.3% +31.3%
ZHENG, LI 2 83.6% +12.9%
STEPHENS, REBECCA JOHANNA 2 67.7% +28.5%
SHEN, YANXIN NMN 2 81.8% +36.4%
NGUYEN, NGHI V 2 53.6% +50.8%
MEADOWS, CHRISTINA L 2 76.1% +23.2%
VARADARAJ, ARCHANA 2 80.0% +33.3%
DEVEAU ROSEN, JASON 2 80.1% +16.5%

Quick Wins (7)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18720593 MODIFIED AGROBACTERIA FOR EDITING PLANTS DEVEAU ROSEN, JASON 66d overdue
18755523 PLANTS WITH INCREASED WATER USE EFFICIENCY ZHENG, LI 17d overdue
18752480 SHATTERPROOF GENES AND MUTATIONS DEVEAU ROSEN, JASON 1d overdue
19223728 LETTUCE VARIETY 'SAN ANGELO' ZHENG, LI —
18972633 SOYBEAN VARIETIES PAGE, BRENT T —
18972620 SOYBEAN VARIETIES '2984004', '2987413', AND '2987331' PAGE, BRENT T —
18832867 MEDICINAL USES OF OLIGOPEPTIDES IN COMBINATION WITH AN ANTIANDROGEN VARADARAJ, ARCHANA —

Hard Cases (162)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17798824 METHOD AND DRUG FOR TREATING VIRAL PNEUMONIA BERKE-SCHLESSEL, DAVID W 259d overdue
17941369 SYSTEMS AND METHODS FOR ONBOARDING AND SUPPORTING CREDIT PRODUCT PARTNERS GREGG, MARY M 167d overdue
18368303 ADAPTIVE SELECTION OF STIMULI FOR NEURO-ACTIVATION SAHAND, SANA 164d overdue
18143989 ADAPTIVE SELECTION OF MESSAGES FOR TRANSMISSION IN NETWORKED ENVIRONMENTS TO INCREASE SESSION ADHERENCE HOLCOMB, MARK 128d overdue
19055495 MODULAR- SEQUENTIAL- HIGH-TEMPERATURE HEAT COLLECTION AND STORAGE DEVICE WITH INTEGRATED POWER CONVERSION UNIT LARGI, MATTHEW THOMAS 126d overdue
17428591 ORAL FORMULATIONS OF A BIOLOGICALLY ACTIVE PEPTIDE AND USES THEREOF PEEBLES, KATHERINE 124d overdue
18357613 SYSTEMS AND METHODS FOR HUMAN-MACHINE PARTNERED PTSD PREDICTION EDWARDS, PHILIP CHARLES 98d overdue
18174000 INTELLIGENT SYSTEMATIC AGENT: AN ENSEMBLE OF DEEP LEARNING AND EVOLUTIONARY STRATEGIES SUSSMAN MOSS, JACOB ZACHARY 66d overdue

Interview Candidates (22)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18720593 MODIFIED AGROBACTERIA FOR EDITING PLANTS DEVEAU ROSEN, JASON 66d overdue
18755523 PLANTS WITH INCREASED WATER USE EFFICIENCY ZHENG, LI 17d overdue
18752480 SHATTERPROOF GENES AND MUTATIONS DEVEAU ROSEN, JASON 1d overdue
17599446 EX VIVO METHODS FOR PRODUCING A T CELL THERAPEUTIC AND RELATED COMPOSITIONS AND METHODS RAHMAN, MASUDUR 7d
19231374 DIGITAL THERAPEUTIC METHOD AND SYSTEM EMPLOYING NUTRITIONAL COGNITIVE BEHAVIORAL THERAPY LULTSCHIK, WILLIAM G 62d
19223728 LETTUCE VARIETY 'SAN ANGELO' ZHENG, LI —
19215928 SOYBEAN VARIETY '20506064' STEPHENS, REBECCA JOHANNA —
19210663 MODIFYING THE SPECIFICITY OF PLANT NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION PAGE, BRENT T —

Client Portfolio (177 clients)

View all 177 →

Top Art Units

Art UnitApps
166311
16628
37977
37955
16745
16435
16374
36824
37984
16524

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19431636 SYSTEMS AND METHODS FOR HIGHLY-PARALLEL TESTING WITH THERMAL CONTROL Aem Singapore Pte. Ltd. VELEZ, ROBERTO 2858 §102§103 Final Rejection — Pending Dec 23, 2025
19399542 METHODS OF FORMING CIRCULARIZED RNA Therorna Inc. ANGELL, JON E 1637 §102§103§112 Non-Final OA — Pending Nov 24, 2025
19316329 SYSTEMS AND METHODS FOR TRANSMISSION OF MEDICAL IMAGE METADATA Stryker Corporation DANG, HUNG Q 2484 §103 Final Rejection — Pending Sep 02, 2025
19288455 MANAGEMENT AND COORDINATION OF DATA FOR DIGITAL THERAPEUTICS TRIALS Click Therapeutics, Inc. EZEWOKO, MICHAEL I §101§103 Non-Final OA — Pending Aug 01, 2025
19283037 SYSTEM AND METHOD FOR SPECTRAL DATA ANALYSIS Avalo, Inc. VARNDELL, ROSS E 2674 §103 Non-Final OA — Pending Jul 28, 2025
19245212 UNIFIED COMMUNICATION AND EQUIPMENT TRACKING MOBILE APPLICATION FOR MEDICAL ENVIRONMENTS Stryker Corporation GARTLAND, SCOTT D 3683 §101§103§112 Non-Final OA — Pending Jun 20, 2025
19240156 OPERATING DEVICES IN AN OPERATING ROOM Stryker Corporation SOREY, ROBERT A §103 Non-Final OA — Pending Jun 17, 2025
19236768 REJECTING SPURIOUS MAGNETIC FIELDS DURING MAGNETIC MARKER LOCALIZATION Stryker Corporation CELESTINE, NYROBI I 3793 §103 Final Rejection — Pending Jun 12, 2025
19231374 DIGITAL THERAPEUTIC METHOD AND SYSTEM EMPLOYING NUTRITIONAL COGNITIVE BEHAVIORAL THERAPY Click Therapeutics, Inc. LULTSCHIK, WILLIAM G 3682 §101§103 Non-Final OA 62d Pending Jun 06, 2025
19231379 DIGITAL THERAPEUTIC METHOD AND SYSTEM EMPLOYING NUTRITIONAL COGNITIVE BEHAVIORAL THERAPY Click Therapeutics, Inc. GEBREMICHAEL, BRUK A 3715 §103 Non-Final OA 98d overdue Pending Jun 06, 2025
19227872 SYSTEMS AND METHODS FOR 3D MODEL BASED DRONE FLIGHT PLANNING AND CONTROL Neural Enterprises Inc. BEAN, JARED C §103Other Non-Final OA — Pending Jun 04, 2025
19223728 LETTUCE VARIETY 'SAN ANGELO' Salinas Valley Seeds, LLC ZHENG, LI 1662 §112 Non-Final OA — Pending May 30, 2025
19216441 NEIGHBORHOOD-GATED SWITCHING PIXEL SENSOR Voxelsensors Srl FOSSELMAN, JOEL W §102§103 Non-Final OA — Pending May 22, 2025
19216652 SYSTEMS AND METHODS FOR DETERMINING TIMING FOR FLUORESCENCE BASED BLOOD FLOW ASSESSMENT Stryker Corporation ALDARRAJI, ZAINAB MOHAMMED 3797 §102§103 Non-Final OA — Pending May 22, 2025
19216373 ENGINEERING CASSAVA FOR IMPROVED GROWTH AND YIELD National Chung Hsing University KEOGH, MATTHEW R §102§103§112 Non-Final OA — Pending May 22, 2025
19215928 SOYBEAN VARIETY '20506064' Gdm Seeds Inc. STEPHENS, REBECCA JOHANNA §112 Non-Final OA — Pending May 22, 2025
19210663 MODIFYING THE SPECIFICITY OF PLANT NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION Tropic Biosciences UK Limited PAGE, BRENT T 1663 §101§102DP Non-Final OA — Pending May 16, 2025
19207213 PRIVACY-CONSCIOUS CONTENT AND ADVERTISEMENT TARGETING 2No, Inc. BEKERMAN, MICHAEL 3621 §101§102§103§112 Non-Final OA 41d Pending May 13, 2025
19126628 REMOVAL TOOL FOR MAGNETIC LOCALIZATION MARKER Stryker Corporation KLEIN, BROOKE L 3797 §103 Final Rejection — Pending May 01, 2025
19189060 TRAVELER TRACKING SYSTEM Nomadix, Inc. VANDERHORST, MARIA VICTORIA §101§103Other Non-Final OA — Pending Apr 24, 2025
19181163 POLYPLOID HYBRID MAIZE BREEDING Ohalo Genetics, Inc. STEPHENS, REBECCA JOHANNA §112DP Non-Final OA — Pending Apr 16, 2025
19173408 SWISS CHARD VARIETY 'RHDF-611 23' Pinnacle Seed, Inc. RADOSAVLJEVIC, ALEKSANDAR §112 Non-Final OA — Pending Apr 08, 2025
19090231 PLANT PROTEIN BASED IMITATION LEATHER FABRIC Uncaged Innovations Inc. IMANI, ELIZABETH MARY COLE 1789 §103 Non-Final OA — Pending Mar 25, 2025
19086929 ENGINEERED RNA DEMETHYLASES FOR IMPROVED PLANT GROWTH The University of Chicago SHEN, YANXIN NMN §102§103§112 Non-Final OA — Pending Mar 21, 2025
19079832 SYSTEMS AND METHODS FOR TRANSMITTING MEDICAL VIDEO DATA IN A BANDWIDTH CONSTRAINED ENVIRONMENT Stryker Corporation OCAK, ADIL 2426 §103 Non-Final OA — Pending Mar 14, 2025
19109411 VISUAL ROBOTIC TASK CONFIGURATION SYSTEM Tutor Intelligence, Inc. LIN, ABBY YEE §103 Non-Final OA — Pending Mar 06, 2025
18722586 LEATHER-LIKE BIOLOGICAL COMPOSITE MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF Shenzhen Institute Of Advanced Technology ZHANG, MICHAEL N §112 Non-Final OA — Pending Feb 21, 2025
19055495 MODULAR- SEQUENTIAL- HIGH-TEMPERATURE HEAT COLLECTION AND STORAGE DEVICE WITH INTEGRATED POWER CONVERSION UNIT Exowatt, Inc. LARGI, MATTHEW THOMAS 3746 §102§103§112 Final Rejection 126d overdue Pending Feb 17, 2025
19055493 COATINGS TO RESIST HIGH-TEMPERATURE OXIDATION IN A THERMAL ENERGY STORAGE SYSTEM Exowatt, Inc. TANENBAUM, TZVI SAMUEL §103§112 Non-Final OA — Pending Feb 17, 2025
19103139 SUITCASE FRAME Atr Brands Limited TAMIL, JESSICA KAVINI 3733 §103§112 Final Rejection 16d Pending Feb 11, 2025
19046351 ITERATIVE RAY-TRACING FOR AUTOSCALING OF OBLIQUE IONOGRAMS Atmospheric & Space Technology Research Associates, L.L.C. LEE, SARAH YEO Other Non-Final OA — Pending Feb 05, 2025
19039724 CHAOTIC STORAGE OF PRESCRIPTION MEDICATIONS Supporting Initiatives to Redistribute Unused Medicine (Sirum) ALDERSON, ANNE-MARIE K 3682 §103 Final Rejection 28d overdue Pending Jan 28, 2025
18998440 PARTICLE CHARACTERISATION Malvern Panalytical Limited LUU, THANH X §102§103 Non-Final OA — Pending Jan 24, 2025
19034403 LIGHT ENGINE SYSTEMS AND METHODS FOR COMBINING LOW AND HIGH ETENDUE LIGHT Stryker Corporation BROOKS, JERRY L. §102§103 Non-Final OA — Pending Jan 22, 2025
19030691 METHOD AND APPARATUS FOR KNOWLEDGE REPRESENTATION AND REASONING IN ACCOUNTING Pwc Product Sales LLC LU, KUEN S 2165 §103 Final Rejection 20d Pending Jan 17, 2025
19030862 SYSTEMS AND METHODS FOR MEDICAL IMAGING USING A ROLLING SHUTTER IMAGER Stryker Corporation BROWN JR, HOWARD D 2488 §103Other Non-Final OA 2d overdue Pending Jan 17, 2025
19021965 SYSTEMS AND METHODS FOR UNDERWEAR FOR USE WITH LIMITED MOBILITY Springrose, Inc. NUNNERY, GRADY ALEXANDER 3732 §103 Non-Final OA 42d Pending Jan 15, 2025
19020993 ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA Snipr Technologies Limited GRASER, JENNIFER E §103DP Non-Final OA — Pending Jan 14, 2025
19018259 SYSTEMS AND METHODS FOR EVALUATING AND IMPROVING NEUROTRANSMITTER LEVELS BASED ON MOBILE DEVICE APPLICATION DATA Matter Neuroscience Inc. KUO, JONATHAN T DP Non-Final OA — Pending Jan 13, 2025
19007181 METHODS AND SYSTEMS FOR NATURAL LANGUAGE PROCESSING OF GRAPH DATABASE QUERIES The MITRE Corporation HUANG, CHENG-FENG 2497 §103 Non-Final OA — Pending Dec 31, 2024
19002403 SYSTEMS AND METHODS FOR IMAGE SEQUENCE REGISTRATION Stryker Corporation FUJITA, KATRINA R §102§103 Non-Final OA — Pending Dec 26, 2024
18878340 LOW VOLTAGE ELECTROLYZER AND METHODS OF USING THEREOF Sublime Systems, Inc. WILKINS III, HARRY D 1794 §102§103 Non-Final OA 30d Pending Dec 23, 2024
18983728 CANISTER WITH A PUMP FOR DISPERSING LIQUIDS AND METHOD OF USING THE SAME Native Pet, Inc. PANCHOLI, VISHAL J §103§112 Non-Final OA — Pending Dec 17, 2024
18983117 PIXEL SENSOR SYSTEM Voxelsensors Srl KO, TONY §102 Non-Final OA — Pending Dec 16, 2024
18873638 IDENTIFICATION AND CHARACTERIZATION OF PANCREATIC CYSTIC LESIONS BAYER AKTIENGESELLSCHAFT VILLECCO, JOHN M §101§102 Non-Final OA — Pending Dec 10, 2024
18972633 SOYBEAN VARIETIES Asociados Don Mario S.A. PAGE, BRENT T 1663 §112 Non-Final OA — Pending Dec 06, 2024
18972620 SOYBEAN VARIETIES '2984004', '2987413', AND '2987331' Asociados Don Mario S.A. PAGE, BRENT T 1663 §112 Non-Final OA — Pending Dec 06, 2024
18969101 MULTISPECIFIC POLYPEPTIDE CONSTRUCTS CONTAINING A CONSTRAINED CD3 BINDING DOMAIN AND A RECEPTOR BINDING REGION AND METHODS OF USING THE SAME Inhibrx Biosciences, Inc. CHEONG, CHEOM-GIL §103§112DP Non-Final OA — Pending Dec 04, 2024
18967146 SELECTIVELY PLATED, FREQUENCY-SCALED ULTRA-WIDEBAND PHASED ARRAY ANTENNA The MITRE Corporation PATEL, AMAL A §103§112 Non-Final OA — Pending Dec 03, 2024
18962355 MACHINE LEARNING ARCHITECTURES TO DETERMINE USER RESPONSIVENESS BASED ON MULTI-MODAL MEASUREMENT DATA Click Therapeutics, Inc. VANDER WOUDE, KIMBERLY ELAINE 3681 §101§103 Non-Final OA — Pending Nov 27, 2024

View all 349 →

Managing Morrison & Foerster LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Morrison & Foerster LLP's patent allowance rate?

78.4% of resolved applications prosecuted by Morrison & Foerster LLP were allowed, across 24,000 applications in USPTO records.

How many office actions does Morrison & Foerster LLP average before allowance?

3.43 office actions per allowed application on average.

How many pending office actions does Morrison & Foerster LLP have?

349 pending office actions as of October 2026, for 177 clients, before 317 examiners in 156 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month